Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections

被引：0
作者：
Gennaro De Pascale
Lucia Lisi
Gabriella Maria Pia Ciotti
Maria Sole Vallecoccia
Salvatore Lucio Cutuli
Laura Cascarano
Camilla Gelormini
Giuseppe Bello
Luca Montini
Simone Carelli
Valentina Di Gravio
Mario Tumbarello
Maurizio Sanguinetti
Pierluigi Navarra
Massimo Antonelli
机构：
[1] Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore,Dipartimento di Scienza dell’Emergenza, Anestesiologiche e della Rianimazione
[2] Università Cattolica del Sacro Cuore, UOC di Anestesia, Rianimazione, Terapia Intensiva e Tossicologia Clinica
[3] Università Cattolica del Sacro Cuore,Istituto di Anestesia e Rianimazione
[4] Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Institute of Farmacologia
[5] Fondazione Policlinico Universitario A. Gemelli IRCCS,Dipartimento di Scienze di Laboratorio e Infettivologiche, UOC di Malattie Infettive
[6] Università Cattolica del Sacro Cuore,Istituto di Malattie Infettive
[7] Università Cattolica del Sacro Cuore,Istituto di Microbiologia
[8] Fondazione Policlinico Universitario A. Gemelli IRCCS,Dipartimento di Scienze di Laboratorio e Infettivologiche, UOC di Microbiologia
来源：
Annals of Intensive Care | / 10卷
关键词：
Tigecycline; High dose; Pharmacokinetics; Epithelial lining fluid; Critically ill patients; Severe infections;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 106 条
[1]  
Testa R(1993)In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines Antimicrob Agents Chemother 37 2270-2277
[2]  
Petersen P(2020)Effectiveness and safety of high dose tigecyclinefor the treatment of severe infections: a systematic review and meta-analysis Adv Ther. 37 1049-1064
[3]  
Jacobus N(2018)In vitro activity of tigecycline and comparators against a European collection of anaerobes collected as part of the Tigecycline Evaluation and Surveillance Trial (TEST) 2010–2016 Anaerobe 51 78-88
[4]  
Sum P(2019)Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: a meta-analysis Medicine 98 e17091-336
[5]  
Lee V(2017)Population pharmacokinetics of tigecycline in critically ill patients with severe infections Antimicrob Agents Chemother 61 e00345-1762
[6]  
Tally F(2013)Tigecycline: an update Diagn Microbiol Infect Dis 75 331-1386
[7]  
Zha L(2013)Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem–cilastatin for treatment of hospital-acquired pneumonia Antimicrob Agents Chemother 57 1756-7
[8]  
Pan L(2014)High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria Crit Care 18 R90-271
[9]  
Guo J(2010)Successful treatment of pan-resistant J Med Microbiol 59 1383-176
[10]  
French N(2014) pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin Int J Antimicrob Agents 44 1-1533
12345678910